Home
Conditions
Lymphoma, Non-Hodgkin

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

1,630 public trials 214 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

Agatolimod Sodium, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent or Refractory Non-Hodgkin Lymphoma

NCT00438880

Conditions: Adult Non-Hodgkin Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +39 more
Locations: University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States

Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Rituximab (Rituxan) for the Prevention of EBV-LPD Epstein Barr Virus (EBV) Lymphoproliferative Disorder Post T Cell Depleted Unrelated and HLA Mis-matched Related HSCT

NCT00648037

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Patients With Low-Grade Non-Hodgkin's Lymphoma Previously Treated With Iodine I 131 Tositumomab

NCT00240578

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: Not specified

View Trial Details

Completed

Phase II Trial of a Chemotherapy Alone Regimen of IV Busulfan (Busulfex), Melphalan and Fludarabine as Myeloablative Regimen Followed by an Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplant From an HLA-Identical, or HLA-Non Identical Related or Unrelated Donor

NCT00582933

Conditions: Allogeneic Marrow Transplant, Bone Marrow Diseases, Hematologic Diseases, +13 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Chemotherapy, Radiation Therapy, Rituximab, and Umbilical Cord Blood Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma

NCT00387959

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +20 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Safety And Efficacy Of Lenalidomide In Patients With Relapsed Or Refractory Aggressive Non-Hodgkin's Lymphoma (NHL)

NCT00179660

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Mayo Clinic Scottsdale Scottsdale, Arizona, United States

Pacific Coast Hematology/Oncology Medical Group, Onc. Fountain Valley, California, United States

UC David Cancer Center Sacramento, California, United States

Sylvester Cancer CenterUniversity Of Miami Miami, Florida, United States

View Trial Details

Completed

Rituximab in Combination With Outpatient Therapy for CD20+ Lymphoma

NCT00280878

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: The Alfred Hospital Melbourne, Victoria, Australia

Frankston Hospital Melbourne, Victoria, Australia

View Trial Details

Completed

Total Body Irradiation/Fludarabine Based Ablative Haploidentical Transplant for Hematologic Diseases

NCT01336712

Conditions: Acute Leukemia, Blood Coagulation Disorders, Blood Platelet Disorders, +21 more
Locations: Northside Hospital Atlanta, Georgia, United States

View Trial Details

Completed

MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma

NCT01748721

Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +103 more
Locations: Children's Hospital of Alabama Birmingham, Alabama, United States

Children's Hospital of Orange County Orange, California, United States

University of California San Francisco Medical Center - Parnassus San Francisco, California, United States

Children's National Medical Center Washington D.C., District of Columbia, United States

View all 20 locations

View Trial Details

Completed

Efficacy Study of Outpatient Therapy for Lymphoma

NCT00163761

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Disease, +9 more
Locations: Canberra Hospital Canberra, Australian Capital Territory, Australia

Royal North Shore Hospital Sydney, New South Wales, Australia

Mater Adult Hospital South Brisbane, Queensland, Australia

Royal Hobart Hospital Hobart, Tasmania, Australia

View Trial Details

Lymphoma, Non-Hodgkin

Lymphoma, Non-Hodgkin trial results

Related conditions